Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of CCX354-C in rheumatoid arthritis patients partially responsive to methotrexate
2010-019964-36Phase 2Completed
- Sponsor
- ChemoCentryx
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing CCX354-C + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: Subject incidence of adverse events. Started May 2010; status: completed.
02
Drugs
CCX354
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-019964-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019964-36.